Ledger.Open graph →
SEC Form D · filed November 19, 2024

Spry Therapeutics Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MUMBAI, MAHARASHTRA, K7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Carl V. Byers · MUMBAI, MAHARASHTRA, K7DirectorGupta V. Shubham · MUMBAI, MAHARASHTRA, K7DirectorPrem V. Pavoor · MUMBAI, MAHARASHTRA, K7DirectorCarl V. Byers · MUMBAI, MAHARASHTRA, K7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗